SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-037957
Filing Date
2023-02-14
Accepted
2023-02-14 11:37:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d424131dsc13g.htm SC 13G 38844
  Complete submission text file 0001193125-23-037957.txt   40075
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Subject) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93731 | Film No.: 23624877
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Gryaznov Sergei (Filed by) CIK: 0001913228 (see all company filings)

Type: SC 13G